BH

Bhagiradha Chemicals and Industries LtdNSE BHAGCHEM Stock Report

Last reporting period 31 Mar, 2024

Updated 24 Oct, 2024

Last price

Market cap $B

0.068

Micro

Exchange

XNSE - National Stock Exchange Of India

BHAGCHEM.NS Stock Analysis

BH

Avoid

Based on Eyestock quantitative analysis, BHAGCHEM.NS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

51/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-84.4 %

Greatly overvalued

Market cap $B

0.068

Dividend yield

0.03 %

Shares outstanding

104.06 B

Bhagiradha Chemicals & Industries Ltd. engages in the manufacture of agrochemicals. The company is headquartered in Hyderabad, Telangana and currently employs 467 full-time employees. The firm has a portfolio of 15 products spread across various insecticides, herbicides and fungicides and other intermediates. The firm operates through the manufacturing and sales of the crop care chemicals segment. Its insecticides include Chlorpyrifos, Chlorpyrifos-Methyl, Diafenthiuron, Fipronil, Dinotefuran, Thiamethoxam, Imidacloprid and Pymetrozine. Its herbicides include Triclopyr, Clodinafop-propargyl and Cloquintocet-Mexyl (Safener). The firm's manufacturing unit is located near the eastern coastal town of Ongole, 300 kilometers north of Chennai. The company has an annual capacity of 3250 tons for the manufacture of various technical grade insecticides, herbicides and fungicides. The company has its footprint in various countries, including Argentina, Korea, Australia, Malaysia, Belgium, Mexico, Brazil, New Zealand, Chile, Portugal, Colombia, South Korea and others.

View Section: Eyestock Rating